Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Farr Nezhat, MD Research Grant in Endometriosis

    Forecasted

    Farr Nezhat, MD Research Grant in Endometriosis supports researchers studying endometriosis through molecular profiling to identify treatment targets and understand links to associated ovarian cancers.

    Browse similar grants
    Cancer Research Grants 2026New Research Grants This Month
    OverviewSimilar Grants
    OverviewSimilar Grants

    Genmab Research Grant Advancing Innovation in Ovarian and Endometrial Cancer

    Genmab Research Grant Advancing Innovation in Ovarian and Endometrial Cancer supports researchers studying folate receptor alpha expression as cancer progresses to guide treatment and improve outcomes.

    Women's Cancer FoundationDue Dec 9, 2026$50,000

    GSK Early Career Endometrial Cancer Research Grant

    GSK Early Career Endometrial Cancer Research Grant supports fellows and early career faculty in innovative endometrial cancer research to generate preliminary data and build research independence.

    Women's Cancer FoundationDue Dec 9, 2026$75,000

    Laughlin Family Foundation Research Grant for High-Grade Uterine Cancer

    Laughlin Family Foundation Research Grant for High-Grade Uterine Cancer supports investigators studying treatment resistance and new therapeutic approaches to improve care for aggressive endometrial cancer.

    Women's Cancer FoundationDue Dec 9, 2026$50,000

    Institute for Surgical Excellence Surgical Innovation Research Grant

    Institute for Surgical Excellence Surgical Innovation Research Grant supports researchers developing AI-enabled endometrial cancer risk tools to advance early detection, prevention, and access to diagnostics.

    Women's Cancer FoundationForecasted Dec 9, 2026$50,000Forecasted

    Natera Research Grant Focused on Innovative Uses of Personalized Molecular Residual Disease Testing in Gynecologic Cancers

    Natera Research Grant Focused on Innovative Uses of Personalized Molecular Residual Disease Testing in Gynecologic Cancers supports researchers studying MRD-guided care to improve cancer management.

    Women's Cancer FoundationForecasted Dec 9, 2026$50,000Forecasted